MMP8 and major depressive disorder: Even if MMP8’s final role in MDD is left to future studies, its expression changes in monocytes could serve as biomarkers in patient stratification and for tailored treatments with novel drugs targeting Mmp8 directly, or pathways leading to Mmp8 expression and activation.